Sreenivasa R Chandana

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik et al. · Journal of Clinical Oncology · 2019 · 590 citations · Full text

Pharmacy, Oncology, Pharmacology +17

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Zev A. Wainberg, Davide Melisi, Teresa Macarulla et al. · The Lancet · 2023 · 439 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

PRIMARY BRAIN TUMORS IN ADULTS

Sreenivasa R Chandana, Sujana Movva, Madan L. Arora et al. · CONTINUUM Lifelong Learning in Neurology · 1994 · 239 citations

Medicine, Neurological Surgery, Oncology +17

Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism

Sreenivasa R Chandana, Michael E. Behen, Csaba Juhász et al. · International Journal of Developmental Neuroscience · 2004 · 230 citations · Full text

Medicine, Neuroscience, Psychiatry +17

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

Veena Shankaran, Joseph M. Unger, Amy K. Darke et al. · JNCI Journal of the National Cancer Institute · 2021 · 68 citations · Full text

Medicine, Biostatistics, Oncology +16